Search
forResearch 10 of 1000+
- Lipoatrophy and severe metabolic disturbance in mice with fat-specific deletion of PPARγ
- Maternal PPARγ protects nursing neonates by suppressing the production of inflammatory milk
- Physiologic functions of PP2A: Lessons from genetically modified mice
- The role of PPAR<i>γ</i>-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology
- Peroxisome proliferator-activated receptors (PPARs) and PPAR agonists: the ‘future’ in dermatology therapeutics?
- Expression of Peroxisome Proliferator Activated Receptors (PPARs) in Human Hair Follicles and PPARα Involvement in Hair Growth
- Functions of peroxisome proliferator‐activated receptors (PPAR) in skin homeostasis
- PPAR-<i>γ</i> Agonists and Their Role in Primary Cicatricial Alopecia
- Advanced Inhibition of Undesired Human Hair Growth by PPARγ Modulation?
- PPAR‐γ signalling as a key mediator of human hair follicle physiology and pathology
Community 10 of 326
- Attempting PP-405 topical gel reformulation
- Quote from Pelage (PP-405) Spokesperson...
- Phase 3 Study for PP405 officially posted
- Pelage Pharmaceuticals Phase 3 Trials for PP405 Start in September 2026
- Pelage have made a new post about PP405
- Pelage will be presenting PP405 at the Masters of Aesthetics which is held from 28-30th August
- Phase 3 for PP405 will now start in 2027
- Why is everyone still arguing about PP405 when clascoterone is already heading toward regulatory submission?
- Did some new info come out about PP405? Everyone seems so pessimistic about it recently and I don’t know why.
- Why PP405 may not be dead just yet